CHD1L Inhibitor OTI-611 Synergizes with Chemotherapy to Enhance Antitumor Efficacy and Prolong Survival in Colorectal Cancer Mouse Models
Rita Sala(University of Bern), Daniel V. LaBarbera(University of Colorado Anschutz Medical Campus)
Cited by 5
Related Papers
HTS discovery of PARP1-HPF1 complex inhibitors in cancer
|SLAS DISCOVERY|2023|7